DACH Pharmacy E-commerce: Revenue Forecast and Market Dynamics to 2025

The DACH region’s pharmacy e-commerce sector continues its trajectory of significant expansion, driven by evolving consumer preferences and digital health infrastructure advancements. This analysis provides a data-driven overview of the market’s current state and projects its revenue growth leading up to 2025, detailing key metrics and underlying dynamics.

DACH Online Pharmacy Market Size and Growth Projections

The DACH e-commerce pharmacy market, encompassing Germany, Austria, and Switzerland, demonstrated robust growth in recent years, propelled by increasing digital adoption and regulatory shifts. In 2023, the aggregated online pharmacy revenue for the region was estimated at €7.8 billion. This figure represents a compound annual growth rate (CAGR) of 14.5% from 2020. Projections indicate a sustained upward trend, with the market anticipated to reach an estimated €10.5 billion by 2025.

Germany remains the dominant market within the DACH trio, contributing approximately 85% of the total regional online pharmacy revenue. The German market’s scale is primarily due to its larger population base and a more mature e-commerce infrastructure, coupled with the progressive implementation of the e.Rezept (electronic prescription). Austria and Switzerland, while smaller in absolute terms, exhibit comparable or even higher per-capita online pharmacy spending growth rates, reflecting strong consumer affinity for digital health services.

The growth is not uniform across all segments. Over-the-Counter (OTC) products and health & beauty items have historically driven a substantial portion of online sales due to fewer regulatory hurdles. However, the introduction and increasing acceptance of e.Rezept in Germany are expected to significantly accelerate the online penetration of prescription (Rx) medications, reshaping the market composition towards 2025.

The projected acceleration in Rx sales growth for Germany underscores the transformative impact of digital infrastructure on market access for prescription drugs. This shift is a critical factor in the overall revenue forecast for the region.

Regulatory Frameworks and Market Enablers

The regulatory environment significantly shapes the DACH online pharmacy landscape. In Germany, the introduction of the e.Rezept has been a pivotal development. Following a phased rollout and mandatory implementation from January 2024 for all statutory health insurance prescriptions, the e.Rezept facilitates a seamless digital pathway for patients to redeem prescriptions online. This mechanism removes previous logistical barriers associated with paper prescriptions, directly impacting the accessibility and convenience of online Rx drug procurement.

Prior to e.Rezept, mail-order pharmacies primarily focused on OTC products, non-prescription medications, and health-related ancillary items. While the European Court of Justice ruling in 2016 allowed German mail-order pharmacies to offer rebates on Rx drugs, the practical implementation of online Rx sales remained limited by the need for physical prescription submission. The e.Rezept addresses this, although specific regulations regarding cold chain logistics for certain medications and controlled substances continue to apply, influencing fulfillment models.

In Austria, the legal framework permits the online sale of OTC medicines, but prescription drugs can only be ordered online from pharmacies that also operate a physical storefront and maintain specific regulatory compliance. Switzerland also operates under a mixed model, with Cantonal (state) regulations playing a significant role. Generally, online sales of Rx drugs are more restrictive than in Germany, often requiring a valid Swiss prescription and sometimes direct consultation with a pharmacist. These differing national regulations mean that while the overall DACH market is strong, the specific growth drivers and product mix vary considerably by country.

Competitive Landscape and Leading E-pharmacies

The DACH online pharmacy market is characterized by a concentrated competitive landscape, with a few major players holding significant market shares. These entities have invested substantially in logistics, digital platforms, and customer acquisition.

Germany:

• Shop Apotheke Europe N.V.: Headquartered in the Netherlands but with a strong focus on the German market, Shop Apotheke Europe is a leading player. Their revenue from the DACH region (primarily Germany) for 2023 was reported at approximately €1.1 billion. The company has diversified its offerings beyond traditional pharmacy products into beauty, personal care, and wellness segments.
• DocMorris (Zur Rose Group AG): A subsidiary of the Swiss-based Zur Rose Group, DocMorris holds a prominent position in the German online pharmacy market, particularly in anticipation of the e.Rezept’s full impact. Zur Rose Group’s overall DACH revenue (including Switzerland) was approximately €1.2 billion in 2023. The group has strategically positioned DocMorris to capitalize on the digital prescription market.
• Other Players: A diverse range of smaller online pharmacies and traditional brick-and-mortar pharmacies with e-commerce extensions also compete, though their individual market shares are comparatively smaller. This includes entities like Medpex (part of Shop Apotheke Europe since 2021) and apodiscounter.de.

Austria and Switzerland: In Austria and Switzerland, the market is more fragmented, with local players and traditional pharmacies having a stronger online presence. Zur Rose Group also operates in Switzerland under its own brand, leveraging its established reputation. However, the cross-border activities of major German players also influence these markets, particularly for OTC products.

The market has witnessed consolidation, exemplified by Shop Apotheke Europe’s acquisition of Medpex in 2021, which enhanced its market leadership. Such strategic moves indicate an ongoing effort by major players to strengthen their positions and expand their customer base in a rapidly evolving market.

Product Categories and Consumer Purchasing Patterns

The product mix within DACH pharmacy e-commerce is evolving, driven by regulatory changes and consumer demand. Historically, Over-the-Counter (OTC) medications, health & beauty products, dietary supplements, and medical devices constituted the majority of online pharmacy sales. This segment benefits from consumer convenience, competitive pricing, and a broader selection often unavailable in local brick-and-mortar pharmacies.

• OTC & Health Products: In 2023, OTC medications and non-pharmaceutical health products accounted for approximately 70% of total online pharmacy revenue in the DACH region. This includes categories such as pain relievers, cold & flu remedies, vitamins, skincare, and personal hygiene items. The growth in this segment is consistently strong, driven by repeat purchases and a shift from physical retail to online channels.
• Prescription (Rx) Medications: The online sale of Rx drugs has been historically limited by logistical and regulatory challenges. However, the introduction of the e.Rezept in Germany is fundamentally altering this. While Rx sales represented a smaller fraction of online pharmacy revenue prior to 2024, projections indicate a significant increase in their share towards 2025. Consumer adoption rates for e.Rezept have shown a steady increase, reaching over 2 million redeemed e.Rezept in Germany by Q4 2023, signaling growing patient trust and familiarity with the digital process. This trend is expected to continue, with the potential for Rx drugs to constitute a substantially larger proportion of online pharmacy revenue.

Consumer purchasing patterns reveal a preference for online channels for routine purchases and for products where privacy or a wider selection is desired. Price comparison capabilities also play a significant role in consumer decisions, particularly for non-prescription items. The integration of loyalty programs and subscription services by leading e-pharmacies further encourages repeat business and customer retention. The average order value (AOV) in DACH online pharmacies typically ranges from €45 to €60, with variations based on product mix and promotional activities. This AOV is often higher than in general e-commerce due to the nature of pharmacy purchases.

Frequently Asked Questions

What is the projected total revenue for DACH pharmacy e-commerce in 2025? The DACH online pharmacy market is forecast to reach an estimated €10.5 billion by 2025. This figure reflects a continued upward trend from €7.8 billion in 2023, driven by evolving consumer preferences and digital health infrastructure advancements.

What is the Compound Annual Growth Rate (CAGR) for DACH online pharmacy revenue from 2023 to 2025? The DACH online pharmacy market is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.9% between 2023 and 2025. This growth rate is an acceleration from the 14.5% CAGR observed from 2020 to 2023.

What share of the DACH online pharmacy revenue is Germany expected to hold by 2025? Germany is projected to increase its market dominance, contributing approximately 87% of the total regional online pharmacy revenue by 2025. This represents a 2 percentage point increase from its 85% share in 2023.

How will online prescription (Rx) sales in Germany contribute to the overall DACH forecast by 2025? Online Rx sales growth in Germany is forecast to accelerate significantly, reaching 35.0% by 2025, up from 25.0% in 2023. This substantial increase is a direct result of the mandatory implementation and growing adoption of the e.Rezept.

For deeper strategic analysis, see our full report.

The DACH pharmacy e-commerce market is projected to reach €10.5 billion by 2025, demonstrating a robust CAGR of 16.9% from 2023. This growth is significantly propelled by the increasing adoption of the e.Rezept in Germany, which is set to boost online Rx sales growth to 35.0% by 2025.